用FEN1进行Prime编辑改善了气道基底细胞中CFTR基因的F508del变异编辑
Olga V Volodina1, Anna G Demchenko1, Arina A Anuchina1,2
1Laboratory of Genome Editing, Research Centre for Medical Genetics, 115522 Moscow, Russia.
International journal of molecular sciences
|August 28, 2025
概括
主编辑显示了纠正导致囊性纤维化 CFTR 变异的前景. 一个改进的PEmax系统,4-FEN,提高了患者细胞的编辑效率,尽管富含AT的区域仍然具有挑战性.
科学领域:
- 基因编辑技术
- 分子生物学
- 基因疾病治疗
背景情况:
- 提供一种潜在的策略来纠正引起疾病的基因突变.
- 主编辑的效率取决于特定的基因组位置和序列上下文.
- CFTR F508del变种是囊性纤维化的一个常见原因,需要有效的基因校正策略.
研究的目的:
- 系统地评估PEmax主要编辑系统的修改以提高效率.
- 评估主要编辑变体在患者衍生细胞中纠正CFTR F508del致病变体的性能.
- 识别可以克服AT丰富基因组区域的挑战的主要编辑器修改.
主要方法:
- 对12个PEmax系统修改进行系统评估.
- 使用EXO1和FEN1核酶来增强主要编辑系统.
- 在携带CFTR F508del变异的患者衍生基底细胞中测试了编辑效率.
主要成果:
- 所有测试的主要编辑器变种在富含AT的目标区域表现出低效率.
- 4-FEN修改显示了编辑率的显著改善,高达标准PEmax的2. 13倍.
- 尽管有了改进,但富含AT的序列仍然是主要编辑的挑战.
结论:
- 优化的原始编辑系统,如4-FEN,可以提高特定致病变体的编辑效率.
- 4-FEN修改显示了更广泛的应用潜力,用于纠正其他基因组目标.
- 需要进一步开发以解决编辑富含AT的基因组序列的固有困难.
相关概念视频
RNA Editing
9.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.2K
Cystic Fibrosis: Management
222
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
222
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
Cystic Fibrosis: Pathogenesis
358
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
358
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K


